Title: Biblio RTF Export
Author: Biblio 7.x

Herndon DR, Ueti MW, Reif KE, Noh SM, Brayton KA, Agnes JT, Palmer GH. Identification of multilocus genetic heterogeneity in Anaplasma marginale subsp. centrale and its restriction following tick-borne transmission. Infect Immun. 2013  ;81(5):1852-8.

Ueti MW, Tan Y, Broschat SL, Ortiz EJCastañe, Camacho-Nuez M, Mosqueda JJ, Scoles GA, Grimes M, Brayton KA, Palmer GH. Expansion of variant diversity associated with a high prevalence of pathogen strain superinfection under conditions of natural transmission. Infect Immun. 2012  ;80(7):2354-60.

Ramabu SS, Schneider DA, Brayton KA, Ueti MW, Graça T, Futse JE, Noh SM, Baszler TV, Palmer GH. Expression of Anaplasma marginale ankyrin repeat-containing proteins during infection of the mammalian host and tick vector. Infect Immun. 2011  ;79(7):2847-55.

Agnes JT, Brayton KA, LaFollett M, Norimine J, Brown WC, Palmer GH. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine. Infect Immun. 2011  ;79(3):1311-8.

Noh SM, Ueti MW, Palmer GH, Munderloh UG, Felsheim RF, Brayton KA. Stability and tick transmission phenotype of gfp-transformed Anaplasma marginale through a complete in vivo infection cycle. Appl Environ Microbiol. 2011  ;77(1):330-4.

Mercado-Curiel RF, Palmer GH, Guerrero FD, Brayton KA. Temporal characterisation of the organ-specific Rhipicephalus microplus transcriptional response to Anaplasma marginale infection. Int J Parasitol. 2011  ;41(8):851-60.

Han S, Norimine J, Brayton KA, Palmer GH, Scoles GA, Brown WC. Anaplasma marginale infection with persistent high-load bacteremia induces a dysfunctional memory CD4+ T lymphocyte response but sustained high IgG titers. Clin Vaccine Immunol. 2010  ;17(12):1881-90.

Agnes JT, Herndon D, Ueti MW, Ramabu SS, Evans M, Brayton KA, Palmer GH. Association of pathogen strain-specific gene transcription and transmission efficiency phenotype of Anaplasma marginale. Infect Immun. 2010  ;78(6):2446-53.

Ramabu SS, Ueti MW, Brayton KA, Baszler TV, Palmer GH. Identification of Anaplasma marginale proteins specifically upregulated during colonization of the tick vector. Infect Immun. 2010  ;78(7):3047-52.

Noh SM, Zhuang Y, Futse JE, Brown WC, Brayton KA, Palmer GH. The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity. Vaccine. 2010  ;28(21):3741-7.

Futse JE, Brayton KA, Nydam SD, Palmer GH. Generation of antigenic variants via gene conversion: Evidence for recombination fitness selection at the locus level in Anaplasma marginale. Infect Immun. 2009  ;77(8):3181-7.

Galletti MFBM, Ueti MW, Knowles DP, Brayton KA, Palmer GH. Independence of Anaplasma marginale strains with high and low transmission efficiencies in the tick vector following simultaneous acquisition by feeding on a superinfected mammalian reservoir host. Infect Immun. 2009  ;77(4):1459-64.

Noh SM, Brayton KA, Brown WC, Norimine J, Munske GR, Davitt CM, Palmer GH. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization. Infect Immun. 2008  ;76(5):2219-26.

Macmillan H, Norimine J, Brayton KA, Palmer GH, Brown WC. Physical linkage of naturally complexed bacterial outer membrane proteins enhances immunogenicity. Infect Immun. 2008  ;76(3):1223-9.

Leverich CK, Palmer GH, Knowles DP, Brayton KA. Tick-borne transmission of two genetically distinct Anaplasma marginale strains following superinfection of the mammalian reservoir host. Infect Immun. 2008  ;76(9):4066-70.

Palmer GH, Brayton KA. Gene conversion is a convergent strategy for pathogen antigenic variation. Trends Parasitol. 2007  ;23(9):408-13.

Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE, Brown WC. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. Infect Immun. 2007  ;75(5):2333-42.

Zhuang Y, Futse JE, Brown WC, Brayton KA, Palmer GH. Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection. Infect Immun. 2007  ;75(11):5185-90.

Palmer GH, Futse JE, Leverich CK, Knowles DP, Rurangirwa FR, Brayton KA. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals. Infect Immun. 2007  ;75(3):1502-6.

Macmillan H, Brayton KA, Palmer GH, McGuire TC, Munske G, Siems WF, Brown WC. Analysis of the Anaplasma marginale major surface protein 1 complex protein composition by tandem mass spectrometry. J Bacteriol. 2006  ;188(13):4983-91.

Noh SM, Brayton KA, Knowles DP, Agnes JT, Dark MJ, Brown WC, Baszler TV, Palmer GH. Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect Immun. 2006  ;74(6):3471-9.

Brayton KA, Palmer GH, Brown WC. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale. Expert Rev Vaccines. 2006  ;5(1):95-101.

Palmer GH, Futse JE, Knowles DP, Brayton KA. Insights into mechanisms of bacterial antigenic variation derived from the complete genome sequence of Anaplasma marginale. Ann N Y Acad Sci. 2006  ;1078:15-25.

Rodríguez J-L, Palmer GH, Knowles DP, Brayton KA. Distinctly different msp2 pseudogene repertoires in Anaplasma marginale strains that are capable of superinfection. Gene. 2005  ;361:127-32.

Barbet AF, Agnes JT, Moreland AL, Lundgren AM, A Alleman R, Noh SM, Brayton KA, Munderloh UG, Palmer GH. Identification of functional promoters in the msp2 expression loci of Anaplasma marginale and Anaplasma phagocytophilum. Gene. 2005  ;353(1):89-97.

Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J, Brown WC. Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun. 2005  ;73(12):8109-18.

Futse JE, Brayton KA, Knowles DP, Palmer GH. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants. Mol Microbiol. 2005  ;57(1):212-21.

Brown WC, Palmer GH, Brayton KA, Meeus PFM, Barbet AF, Kegerreis KA, McGuire TC. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3. Infect Immun. 2004  ;72(6):3688-92.

Stich RW, Olah GA, Brayton KA, Brown WC, Fechheimer M, Green-Church K, Jittapalapong S, Kocan KM, McGuire TC, Rurangirwa FR, et al. Identification of a novel Anaplasma marginale appendage-associated protein that localizes with actin filaments during intraerythrocytic infection. Infect Immun. 2004  ;72(12):7257-64.

Palmer GH, Knowles DP, Rodríguez J-L, Gnad DP, Hollis LC, Marston T, Brayton KA. Stochastic transmission of multiple genotypically distinct Anaplasma marginale strains in a herd with high prevalence of Anaplasma infection. J Clin Microbiol. 2004  ;42(11):5381-4.

Meeus PFM, Brayton KA, Palmer GH, Barbet AF. Conservation of a gene conversion mechanism in two distantly related paralogues of Anaplasma marginale. Mol Microbiol. 2003  ;47(3):633-43.

Brown WC, Brayton KA, Styer CM, Palmer GH. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates. J Immunol. 2003  ;170(7):3790-8.

Brayton KA, Meeus PFM, Barbet AF, Palmer GH. Simultaneous variation of the immunodominant outer membrane proteins, MSP2 and MSP3, during anaplasma marginale persistence in vivo. Infect Immun. 2003  ;71(11):6627-32.

Löhr CV, Brayton KA, Shkap V, Molad T, Barbet AF, Brown WC, Palmer GH. Expression of Anaplasma marginale major surface protein 2 operon-associated proteins during mammalian and arthropod infection. Infect Immun. 2002  ;70(11):6005-12.

Shkap V, Molad T, Brayton KA, Brown WC, Palmer GH. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates. Infect Immun. 2002  ;70(2):642-8.